恒瑞医药(600276)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600276 恒瑞医药

已收盘 01-13 15:00:00

{"stockData":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恒瑞医药","latestPrice":64.52,"timestamp":1768287600000,"preClose":63.85,"halted":0,"volume":74034035,"delay":0,"changeRate":0.0105,"floatShares":6379000000,"shares":6637000000,"eps":1.1252,"marketStatus":"已收盘","change":0.67,"latestTime":"01-13 15:00:00","open":64.3,"high":65.83,"low":64.05,"amount":4819000000,"amplitude":0.0279,"askPrice":64.52,"askSize":1280,"bidPrice":64.51,"bidSize":1590,"shortable":0,"etf":0,"ttmEps":1.1252,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":63.85,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":70.24,"lowLimit":57.47,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6637199874,"isCdr":false,"pbRate":7.2,"roa":"--","peRate":57.340917,"roe":"11.09%","epsLYR":1,"committee":0.121096,"marketValue":428232000000,"turnoverRate":0.0116,"status":0,"hkstockBrief":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恒瑞医药","latestPrice":78.7,"timestamp":1768291693004,"preClose":76.95,"halted":0,"volume":2500823,"delay":0,"premium":"+9.05"},"floatMarketCap":411572999999.9999},"requestUrl":"/m/hq/s/600276","defaultTab":"news","newsList":[{"id":"2602498075","title":"恒瑞医药(01276)： HRS-7535 片拟用于高血压合并超重或肥胖治疗获批开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2602498075","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602498075?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:45","pubTimestamp":1768229113,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药 公布，近日，公司子公司山东盛迪医药有限公司收到国家药品监督管理局核准签发关于 HRS-7535 片的《药物临床试验批准通知书》，将于近期开展临床试验。根据《中华人民共和国药品管理法》及有关规定，经审查，2025 年 10 月 27 日受理的 HRS-7535 片符合药品注册的有关要求，同意本品开展临床试验。截至目前，HRS-7535 片相关项目累计研发投入约 36,940 万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1255011170.USD","LU2097828714.EUR","LU2328871848.SGD","LU2097828805.USD","LU2580892862.HKD","LU1580142542.USD","LU1064131003.USD","LU0359201885.HKD","BK0060","LU2097828631.EUR","01276","BK0012","BK0028","LU1781817850.SGD","LU0359201612.USD","LU1997244956.HKD","BK1191","LU0405327494.USD","LU2097828474.EUR","600276","LU0405327148.USD","LU1146622755.USD","LU2148510915.USD","BK0183","LU2580892789.USD","BK0196","LU1820825898.SGD","LU1064130708.USD","LU2289578879.USD","LU1023057109.AUD","LU0359202008.SGD","BK0188","LU1969619763.USD","LU1997245177.USD","LU2495084118.USD","LU2097828557.USD","LU1328615791.USD","LU2543165471.USD","BK0239","LU2488822045.USD","LU1997245094.SGD","LU1655091616.SGD"],"gpt_icon":0},{"id":"2602925995","title":"智通AH统计|1月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2602925995","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602925995?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:15","pubTimestamp":1768205705,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止1月12日收盘，东北电气、浙江世宝、南京熊猫电子股份分列AH溢价率前三位，溢价率分别为770.97%、432.48%、288.23%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-12.93%、-2.18%、-0.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348827113.USD","LU0359202008.SGD","LU0266512127.USD","LU0359201612.USD","LU2476274308.USD","LU2097828557.USD","399300","LU2097828631.EUR","LU0862451753.SGD","BK1594","BK1514","LU0072913022.USD","LU0348825331.USD","LU1785774172.SGD","159982","BK1521","LU0648948544.HKD","LU1023057109.AUD","LU0384037296.USD","LU0348816934.USD","600276","LU0918141705.HKD","LU1008478684.HKD","LU0640798160.USD","LU1115378108.SGD","LU0572940350.SGD","LU0106252389.USD","IE00B031HY20.USD","LU1831875114.USD","BK1509","LU1481107354.HKD","LU1993786604.SGD","LU0173614495.USD","BK1522","LU2226246903.HKD","LU0972618739.USD","LU0543330566.HKD","00553","HK0000352382.USD","LU2778985437.USD","LU0327786744.USD","BK1137","LU0823426480.USD","00042","LU0326950275.SGD","IE00BGHQDM52.EUR","LU0589944569.HKD","LU0049853897.USD","BK1205","LU0456854461.SGD","LU0455707207.USD","LU0502904849.HKD","LU1770034418.SGD","BK1171","BK1191","LU0231483743.USD","LU0588546209.SGD","BK1584","BK1562","IE00B543WZ88.USD","LU0287142896.SGD","SG9999006597.SGD","SG9999004220.SGD","IE0031814852.USD","LU0348788117.USD","LU0540923850.HKD","LU0417516738.SGD","LU1224709979.USD","LU0320764599.SGD","LU2039709279.SGD","002703","LU2045819591.USD","LU2125910500.SGD","IE0032431581.USD","SG9999012710.SGD","LU2097828474.EUR","LU1303224171.USD","SG9999002828.SGD","LU1808992512.USD","SG9999012744.USD","SG9999014674.SGD","LU0561508036.HKD","LU0370786039.SGD","IE00BZ08YR35.GBP","BK1183","LU1960683339.HKD","LU0348814723.USD","03143","600036","BK1546","IE00BYV24P56.USD","LU0348805143.USD","HK0000165453.HKD","LU0737861699.HKD","LU1794554557.SGD","LU0509642566.USD","CIHKY","HK0000306685.HKD","LU0048580855.USD","BK1516","LU0269904917.USD","LU0329678170.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","LU0456827905.SGD","01057","LU0052750758.USD","LU0516422952.EUR","LU1282649141.HKD","BK1144","600775","BK1214","LU1046422090.SGD","LU0264606111.USD","BK1231","LU0345780281.USD","LU0593848301.USD","LU1655091616.SGD","LU1688375341.USD","LU0039217434.USD","LU1720050803.USD","300750","LU0516423174.USD","HK0000320264.USD","LU0106959298.USD","01812","LU0516422440.USD","LU0229945570.USD","LU2543165471.USD","LU1282649067.USD","LU2476274720.SGD","LU1719994722.HKD","BK1170","LU0572939691.SGD","BK1505","LU0797268264.HKD","02691","LU0417516902.SGD","BK1507","BK1592","LU0307460666.USD","LU1226287529.USD","LU0469268626.HKD","BK1148","002202","BK1202","LU0096374516.USD","LU0140636845.USD","LU0266512473.USD","LU0488056044.USD","LU0211977185.USD","BK1550","BK1560","BK1610","LU0067412154.USD","IE0008368742.USD","LU0228659784.USD","LU1675838814.USD","BK1554","LU0516422366.SGD","BK1558","BK1583","03968","LU0791590937.USD","BK1237","LU1105468828.SGD","LU0708995583.HKD","SG9999012728.SGD","LU2097828714.EUR","HK0000320223.HKD","LU0348735423.USD","LU1251922891.USD","BK1564","IE0008369823.USD","BK1105","BK1501","IE00B0169L03.USD","LU0163747925.USD","LU0328353924.USD","LU1152091168.USD","BK1149","BK1526","LU0314109678.HKD","LU1282649810.SGD","IE00B5MMRT66.SGD","BK1184","LU0880133367.SGD","IE00BF5LJ272.USD","LU1366334651.USD","LU2097828805.USD","BK1576","SG9999002463.SGD","LU0061477393.USD","BK1513","LU1242518931.SGD","LU0828237940.HKD","LU1769817179.HKD","LU0345780521.USD","IE00B29SXG58.USD","LU2399975544.HKD","LU0228367735.SGD","LU1769817096.USD","LU0456846285.SGD","IE0034224299.USD","BK1198","LU0871576103.HKD","LU2242644610.SGD","LU1242518857.USD","BK1116","BK1544","SG9999012736.USD","LU0531971595.HKD","LU0572944931.SGD","LU0181495838.USD","000488","LU0821914370.USD","LU0791591158.USD","LU1211504680.USD","IE00BZ08YT58.USD","LU0315179316.USD","LU0868486357.SGD","LU0463099449.HKD","LU0886674414.USD","LU1328277881.USD","LU1880383440.USD","BK1141","IE00BMCWC346.EUR","LU1807302812.USD","LU0823426308.USD","LU1504937902.USD","IE00B031J352.USD","LU0149721374.USD","LU0051755006.USD","IE00BVYPNQ40.USD","LU0890818403.SGD","LU1048596156.SGD","LU1152091754.HKD","LU1282648689.USD","LU0164865239.USD","HK0000352291.HKD","IE00BVYPNP33.GBP","LU0737861772.HKD","LU1961090484.USD","LU0329678337.USD","IE00B3M56506.USD","LU0117841782.USD","LU0634319403.HKD","LU0828237510.HKD","LU0828238088.HKD","LU1366334578.USD","LU1188198961.HKD","LU0359201885.HKD","LU1813983027.USD","LU0918141887.USD","HK0000306701.USD","LU1880383366.USD","LU0244354667.USD","LU0431992006.USD","BK1163","LU0516423091.SGD","LU0979878070.USD","BK1147","BK1551","LU0164880469.USD","01276","BK1223"],"gpt_icon":1},{"id":"2602383553","title":"恒瑞医药获小摩增持约112.78万股 每股作价约74.61港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602383553","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602383553?lang=zh_cn&edition=full","pubTime":"2026-01-11 16:24","pubTimestamp":1768119840,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，1月6日，小摩增持恒瑞医药（01276）112.7828万股，每股作价74.6126港元，总金额约为8415.02万港元。增持后最新持股数目约为1919.4万股，最新持股比例为7.43%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-11/doc-inhfxmcp3824639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1064131342.USD","LU1244550577.SGD","IE00BLSP4452.SGD","LU2211815571.USD","LU1894683348.USD","IE00BBT3K403.USD","LU0106831901.USD","LU0820561909.HKD","LU0417517546.SGD","LU2213496289.HKD","LU2237443549.SGD","IE00BHPRN162.USD","LU0820561818.USD","LU1894683264.USD","LU2580892862.HKD","LU1668664300.SGD","LU2097828805.USD","IE000M9KFDE8.USD","LU0211328371.USD","IE00BN8TJ469.HKD","LU0323591593.USD","LU2552382132.HKD","01276","IE00B1BXHZ80.USD","BK0183","600276","LU0238689110.USD","LU0070302665.USD","LU0256863811.USD","LU0820562030.AUD","LU2097828714.EUR","LU0345769631.USD","LU2552382058.USD","LU0787776722.HKD","LU2097828631.EUR","LU2237443622.USD","LU2417539215.USD","LU0251132253.USD","BK0188","LU1162221912.USD","LU2505996681.GBP","LU0203345920.USD","LU0265550359.USD","BK4516","LU0320765489.SGD","LU2430703095.HKD","LU0868494708.USD","BK0196","LU2456880835.USD","IE00BJLML261.HKD"],"gpt_icon":0},{"id":"2602375349","title":"恒瑞医药：卡瑞利珠单抗在美国的BLA重新上市申报公司正在与FDA积极沟通","url":"https://stock-news.laohu8.com/highlight/detail?id=2602375349","media":"证券日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602375349?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:33","pubTimestamp":1767962029,"startTime":"0","endTime":"0","summary":"证券日报网讯1月9日，恒瑞医药在互动平台回答投资者提问时表示，卡瑞利珠单抗在美国的BLA重新上市申报公司正在与FDA积极沟通，相关事项如有进展公司将严格按照相关规定进行公告，履行信息披露义务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601093614449751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","600276","LU2097828805.USD","LU2543165471.USD","LU1580142542.USD","LU2097828714.EUR","LU1997245177.USD","LU2488822045.USD","BK0028","LU0405327148.USD","LU2580892862.HKD","LU1655091616.SGD","LU2148510915.USD","BK0060","LU1820825898.SGD","LU0359201612.USD","LU0359201885.HKD","LU2580892789.USD","BK0196","LU1969619763.USD","01276","BK0239","LU1064131003.USD","LU1146622755.USD","LU2495084118.USD","LU1997245094.SGD","LU1997244956.HKD","LU2097828631.EUR","LU1023057109.AUD","LU2097828474.EUR","LU0405327494.USD","LU2328871848.SGD","BK0183","BK0012","LU1064130708.USD","LU2097828557.USD","LU1781817850.SGD","LU2289578879.USD","LU0359202008.SGD","LU1255011170.USD","LU1328615791.USD","BK1191"],"gpt_icon":0},{"id":"2602378049","title":"恒瑞医药：公司前瞻性地广泛布局多个治疗领域，并向纵深发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2602378049","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602378049?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:05","pubTimestamp":1767960346,"startTime":"0","endTime":"0","summary":"证券日报网讯1月9日，恒瑞医药在互动平台回答投资者提问时表示，公司前瞻性地广泛布局多个治疗领域，并向纵深发展。公司在肿瘤领域有丰富的研发管线，与此同时，在代谢和心血管疾病、免疫和呼吸系统疾病、神经科学等领域也进行了广泛布局，打造长期发展的多元化战略支柱。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601093614409744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0196","LU1064130708.USD","LU1146622755.USD","LU2097828714.EUR","BK0239","600276","LU1580142542.USD","LU2097828631.EUR","LU2097828805.USD","LU0405327148.USD","LU2097828557.USD","LU1781817850.SGD","LU1997245094.SGD","LU2289578879.USD","LU0405327494.USD","BK0012","LU2580892789.USD","LU2097828474.EUR","01276","LU1655091616.SGD","LU2328871848.SGD","LU0359201885.HKD","BK1191","LU1820825898.SGD","BK0183","LU1328615791.USD","LU1023057109.AUD","LU1255011170.USD","LU2488822045.USD","LU0359202008.SGD","BK0028","LU2543165471.USD","LU2580892862.HKD","LU1969619763.USD","LU0359201612.USD","LU2148510915.USD","BK0188","LU1997245177.USD","LU1997244956.HKD","LU2495084118.USD","BK0060","LU1064131003.USD"],"gpt_icon":0},{"id":"2602547378","title":"小摩增持恒瑞医药(01276)约112.78万股 每股作价约74.61港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602547378","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602547378?lang=zh_cn&edition=full","pubTime":"2026-01-09 19:29","pubTimestamp":1767958148,"startTime":"0","endTime":"0","summary":"1月6日，小摩增持恒瑞医药(01276)112.7828万股，每股作价74.6126港元，总金额约为8415.02万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260109/20260109193002_54761.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260109/20260109193002_54761.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1974910355.USD","LU0256863811.USD","LU2746668461.USD","BK0196","LU0323591593.USD","IE00BLSP4452.SGD","LU0689472784.USD","LU0820561818.USD","LU1551013342.USD","LU1255011170.USD","LU1668664300.SGD","LU1894683264.USD","IE00BDRTCR15.USD","LU1084165304.USD","LU1145028129.USD","LU1146622755.USD","LU1997244956.HKD","600276","LU1328615791.USD","IE0034235295.USD","LU2242649171.HKD","LU1119994496.HKD","LU2357305700.SGD","LU2264538146.SGD","BK4533","LU1116320737.USD","LU2023250330.USD","IE00BJTD4V19.USD","LU2756315664.SGD","IE00BKVL7J92.USD","LU1548497426.USD","BK0012","LU0405327148.USD","BK4550","LU0417517546.SGD","LU0971096721.USD","01276","LU2237443549.SGD","LU2580892789.USD","LU0640476718.USD","LU1720051017.SGD","LU0215105999.USD","LU1267930490.SGD","LU2552382215.SGD","LU0234572021.USD","IE00BLSP4239.USD","LU1064131342.USD","LU1244550494.USD","LU1720051108.HKD","LU2097828805.USD"],"gpt_icon":0},{"id":"2602429324","title":"“年度最受关注IPO公司”榜单出炉，宁德时代、地平线等领军新经济板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2602429324","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602429324?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:45","pubTimestamp":1767951913,"startTime":"0","endTime":"0","summary":"2025香港财富管理高峰论坛暨第十二届港股100强颁奖盛典正在隆重举行，各项榜单陆续揭晓。“年度最受关注IPO公司”榜单已揭晓。宁德时代（03750.HK）、美的集团（00300.HK）、恒瑞医药（01276.HK）、紫金黄金国际（02259.HK）、海天味业（03288.HK）等各领域领军企业集体入选。该榜单囊括新能源、智能制造、生物医药、新消费及人工智能等多元赛道，展现出资本市场对新经济企业的强烈关注。这些新上市企业凭借创新动能与成长潜力，正共同塑造港股市场的新格局，为投资者提供把握未来趋势的重要参考。作者|毛婷编辑|Danna","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109175936a4afd9b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109175936a4afd9b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1993786604.SGD","LU0067412154.USD","LU1807302812.USD","300750","LU1152091754.HKD","600276","LU1152091168.USD","03288","00300","000333","BK1610","LU1960683339.HKD","603288","01276","BK1116","LU0880133367.SGD","03750","LU1008478684.HKD","02259"],"gpt_icon":0},{"id":"2602326203","title":"恒瑞医药：注射用SHR-4394获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2602326203","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602326203?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:09","pubTimestamp":1767949759,"startTime":"0","endTime":"0","summary":"21智讯1月9日电，恒瑞医药公告，恒瑞医药收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意注射用SHR-4394开展临床试验。审批结论显示，该药物符合药品注册相关要求，同意开展SHR-4394或HRS-5041联合抗肿瘤治疗在前列腺癌参与者中的安全性、耐受性及有效性的多中心、开放II期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601093614272360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0405327148.USD","LU1064131003.USD","LU2488822045.USD","LU2097828805.USD","LU1655091616.SGD","LU2097828631.EUR","LU0359202008.SGD","BK0196","BK0060","LU1969619763.USD","LU2097828714.EUR","LU2495084118.USD","01276","LU1997244956.HKD","BK0012","BK1191","LU1023057109.AUD","LU2580892789.USD","LU2580892862.HKD","LU1580142542.USD","LU2097828474.EUR","LU0359201612.USD","BK0183","BK0239","LU1781817850.SGD","LU2148510915.USD","LU0405327494.USD","LU1820825898.SGD","LU2328871848.SGD","600276","LU1146622755.USD","LU1997245094.SGD","LU1997245177.USD","LU1328615791.USD","LU2543165471.USD","LU1255011170.USD","LU2097828557.USD","LU2289578879.USD","BK0028","LU1064130708.USD","BK0188","LU0359201885.HKD"],"gpt_icon":0},{"id":"2602332362","title":"智通AH统计|1月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2602332362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602332362?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:15","pubTimestamp":1767946505,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止1月9日收盘，东北电气、浙江世宝、南京熊猫电子股份分列AH溢价率前三位，溢价率分别为785.25%、448.59%、286.79%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-10.95%、-1.58%、-0.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0588546209.SGD","LU0384037296.USD","LU1188198961.HKD","BK1505","LU0456827905.SGD","IE00BZ08YT58.USD","LU0163747925.USD","IE00B3M56506.USD","BK1521","LU0348805143.USD","LU0370786039.SGD","LU1046422090.SGD","LU1152091754.HKD","LU1808992512.USD","LU0329678337.USD","SG9999012736.USD","LU1481107354.HKD","LU0572944931.SGD","LU0918141887.USD","LU0431992006.USD","LU1282649810.SGD","BK1564","LU2097828805.USD","LU0359201612.USD","LU0320764599.SGD","159982","IE00B031J352.USD","LU1880383440.USD","LU2226246903.HKD","LU2045819591.USD","LU0039217434.USD","LU1328277881.USD","LU0266512127.USD","LU1655091616.SGD","LU2242644610.SGD","LU0871576103.HKD","00553","LU0061477393.USD","LU1152091168.USD","SGXZ90724238.SGD","LU0314109678.HKD","IE0034224299.USD","LU1115378108.SGD","LU0052750758.USD","LU0516422440.USD","BK1223","LU0326950275.SGD","LU0516422952.EUR","LU1504937902.USD","LU0048580855.USD","LU0737861772.HKD","LU2039709279.SGD","LU1831875114.USD","BK1110","BK1148","601995","LU0868486357.SGD","LU0328353924.USD","LU2097828631.EUR","IE00BYV24P56.USD","BK1147","BK1562","LU0287142896.SGD","LU1769817096.USD","IE00BVYPNQ40.USD","LU1242518931.SGD","LU1008478684.HKD","IE00BVYPNP33.GBP","LU0348735423.USD","LU0880133367.SGD","SG9999002828.SGD","BK1141","LU0516423174.USD","LU0589944569.HKD","IE0008369823.USD","BK1171","LU0067412154.USD","BK1560","LU0173614495.USD","LU0862451753.SGD","SG9999002950.SGD","HK0000306685.HKD","BK1509","LU0307460666.USD","LU2097828557.USD","LU1303224171.USD","LU0327786744.USD","LU1366334651.USD","03968","LU0648948544.HKD","LU0106252389.USD","LU0244354667.USD","LU0348816934.USD","01276","LU0488056044.USD","BK1183","LU0516423091.SGD","BK1592","LU0469268626.HKD","LU1813983027.USD","LU0096374516.USD","LU0359201885.HKD","LU1807302812.USD","LU0051755006.USD","HK0000320264.USD","IE00BF5LJ272.USD","LU0345780281.USD","SG9999006597.SGD","BK1191","LU0417516738.SGD","BK1149","BK1584","LU0269904917.USD","BK1144","LU2399975544.HKD","SG9999003461.SGD","LU0455707207.USD","BK1550","BK1202","LU0509642566.USD","LU0791591158.USD","BK1205","LU0456854461.SGD","BK1522","LU0640798160.USD","LU0315179316.USD","LU0516422366.SGD","LU0543330566.HKD","LU1366334578.USD","LU1675838814.USD","LU0972618739.USD","LU0164880469.USD","LU1993786604.SGD","LU1211504680.USD","LU2476274720.SGD","LU2543165471.USD","LU2778985437.USD","600775","LU0149721374.USD","BK1516","LU0502904849.HKD","LU0821914370.USD","LU0561508036.HKD","LU1224709979.USD","300750","LU0211977185.USD","LU1961090484.USD","LU0797268264.HKD","IE0032431581.USD","IE00BMCWC346.EUR","SG9999012710.SGD","03143","03750","BK1221","002703","SG9999001051.SGD","LU0593848301.USD","LU0791590937.USD","BK1554","SG9999012728.SGD","BK1501","600036","LU1023057109.AUD","LU0979878070.USD","LU0228367735.SGD","LU0348827113.USD","LU1688375341.USD","BK1551","LU0072913022.USD","IE00B0169L03.USD","BK1526","LU1282649141.HKD","BK1116","LU0886674414.USD","600276","LU0329678170.USD","BK1610","BK1594","LU1282649067.USD","LU1794554557.SGD","BK1214","SG9999002463.SGD","LU0463099449.HKD","LU1719994722.HKD","00042","LU2476274308.USD","LU1048596156.SGD","002202","BK1546","LU0106959298.USD","LU0359202008.SGD","LU0456846285.SGD","LU0266512473.USD","LU0345780521.USD","LU0828237510.HKD","LU0164865239.USD","BK1558","IE00BGHQDM52.EUR","LU0348788117.USD","LU0828237940.HKD","BK1583","01057","HK0000320223.HKD","LU1105468828.SGD","LU1720050803.USD","LU1880383366.USD","SG9999014674.SGD","LU0501845795.SGD","LU2097828714.EUR","IE00B29SXG58.USD","LU0918141705.HKD","IE00B543WZ88.USD","LU1226287529.USD","BK1184","399300","BK1513","BK1507","LU0229945570.USD","HK0000165453.HKD","LU0231483743.USD","LU0540923850.HKD","LU0634319403.HKD","LU0823426308.USD","LU0828238088.HKD","LU1242518857.USD","LU1251922891.USD","LU1769817179.HKD","LU0737861699.HKD","LU2097828474.EUR","SG9999001069.SGD","LU0140636845.USD","CIHKY","LU1770034418.SGD","BK1514","IE00BZ08YS42.EUR","LU0531971595.HKD","LU0348825331.USD","LU1282648689.USD","000488","LU0181495838.USD","LU1960683339.HKD","LU0117841782.USD","LU0417516902.SGD","SG9999001093.SGD","IE0031814852.USD","LU0049853897.USD","IE0008368742.USD","IE00B5MMRT66.SGD","01812","BK1137","BK1237","LU0348814723.USD","LU0823426480.USD","BK1170","LU1785774172.SGD","LU0708995583.HKD","03908","BK1198","IE00B031HY20.USD","LU0228659784.USD","IE00BZ08YR35.GBP","BK1544","BK1565","BK1576","SG9999004220.SGD","SG9999012744.USD","LU2125910500.SGD","BK1163","BK1231","LU0890818403.SGD","HK0000306701.USD"],"gpt_icon":1},{"id":"2601533894","title":"宜明昂科与Axion“分手”；江西省卫健委党组书记被查","url":"https://stock-news.laohu8.com/highlight/detail?id=2601533894","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601533894?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:41","pubTimestamp":1767832919,"startTime":"0","endTime":"0","summary":"政策动向国家药监局：优化临床急需境外已上市药品审评审批央视新闻消息显示，为加快临床急需境外已上市药品在境内上市，满足患者临床用药迫切需求，国家药监局进一步优化这类药品审评审批。国家药监局表示，坚持以临床价值为导向，鼓励申请人在中国开展全球同步研发、同步申报上市；鼓励临床急需境外已上市的原研药及仿制药在境内申报，对于符合要求的可纳入优先审评审批范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601083612141760.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601083612141760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2097828714.EUR","LU0405327148.USD","LU2488822045.USD","LU1997245177.USD","600276","BK0046","LU2148510915.USD","BK0188","LU1328615791.USD","BK0077","BK0012","BK0114","LU1255011170.USD","BK0239","BK0028","LU1997245094.SGD","LU2097828631.EUR","LU2580892862.HKD","BK0183","LU2097828474.EUR","BK0236","300653","LU2328871848.SGD","LU0405327494.USD","LU1997244956.HKD","688759","BK0196","BK0096","LU1820825898.SGD","LU2097828557.USD","LU1146622755.USD","LU2289578879.USD","LU2580892789.USD","LU1969619763.USD","LU1580142542.USD","LU1781817850.SGD","BK0060","002173","LU1064131003.USD","BK0251","LU1064130708.USD","688321","LU1655091616.SGD","LU2097828805.USD","LU2495084118.USD"],"gpt_icon":0},{"id":"2601871257","title":"恒瑞医药：瑞拉芙普α注射液获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2601871257","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601871257?lang=zh_cn&edition=full","pubTime":"2026-01-07 18:24","pubTimestamp":1767781450,"startTime":"0","endTime":"0","summary":"人民财讯1月7日电，恒瑞医药(600276)1月7日公告，近日，公司子公司苏州盛迪亚生物医药有限公司收到国家药监局的通知，批准公司自主研发的1类创新药瑞拉芙普α注射液上市。该药品联合氟尿嘧啶类和铂类药物用于经充分验证的检测评估PD-L1阳性（CPS≥1）的局部晚期不可切除、复发或转移性胃及胃食管结合部腺癌的一线治疗。经查询，国内外尚无同类产品获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601073611587624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2097828805.USD","LU2488822045.USD","LU2543165471.USD","LU1997244956.HKD","LU1580142542.USD","LU2495084118.USD","LU2580892789.USD","01276","LU1969619763.USD","LU0359202008.SGD","600276","BK0188","BK0239","BK0028","BK0012","LU2148510915.USD","LU0405327148.USD","LU1255011170.USD","LU1655091616.SGD","BK0060","BK0183","LU1820825898.SGD","LU0359201612.USD","LU1997245177.USD","BK0196","LU0359201885.HKD","LU1064130708.USD","LU2097828557.USD","LU1997245094.SGD","LU2097828631.EUR","LU1781817850.SGD","LU2328871848.SGD","LU2580892862.HKD","LU1146622755.USD","LU2097828474.EUR","LU2097828714.EUR","BK1191","LU1328615791.USD","LU1064131003.USD","LU2289578879.USD","LU0405327494.USD","LU1023057109.AUD"],"gpt_icon":0},{"id":"2601685608","title":"恒瑞医药2025年12月股份变动：A股员工持股计划致总股本微增","url":"https://stock-news.laohu8.com/highlight/detail?id=2601685608","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601685608?lang=zh_cn&edition=full","pubTime":"2026-01-06 11:52","pubTimestamp":1767671537,"startTime":"0","endTime":"0","summary":"中访网数据 江苏恒瑞医药股份有限公司于2026年1月5日发布了截至2025年12月31日的证券变动月报表。报告显示，公司总股本在报告期内略有增加。此次A股股份的增加，源于公司根据其2022年、2023年、2024年及2025年A股员工持股计划进行的股份授予或归属，本月内因此新增发行了3,738,950股A股。本次变动后，江苏恒瑞医药的总已发行股份数达到6,637,199,874股。公司库存股份数量在本月内未发生变动，A股和H股的库存股份数均为零。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260106/31918645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1146622755.USD","LU1820825898.SGD","LU0405327494.USD","BK0060","BK0188","LU2097828474.EUR","LU2543165471.USD","LU1255011170.USD","LU1064131003.USD","LU2289578879.USD","BK0196","LU1781817850.SGD","LU0359201885.HKD","LU2097828714.EUR","LU0359202008.SGD","01276","LU2328871848.SGD","LU0405327148.USD","LU2580892862.HKD","LU2097828805.USD","159982","BK0183","LU0359201612.USD","LU2495084118.USD","LU1969619763.USD","BK0028","LU2097828631.EUR","BK0239","BK0012","LU1023057109.AUD","BK1191","LU2097828557.USD","LU1997245177.USD","LU1064130708.USD","LU1997244956.HKD","LU1997245094.SGD","LU1580142542.USD","LU1655091616.SGD","LU2148510915.USD","600276","LU2488822045.USD","LU1328615791.USD","LU2580892789.USD","399300"],"gpt_icon":0},{"id":"2601004192","title":"恒瑞医药：子公司收到药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2601004192","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601004192?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:09","pubTimestamp":1767604169,"startTime":"0","endTime":"0","summary":"每经AI快讯，1月5日，恒瑞医药公告，恒瑞医药收到国家药品监督管理局核准签发的关于HRS-4357注射液、HRS-5041片的《药物临床试验批准通知书》，同意开展临床试验。具体为：HRS-4357联合HRS-5041用于PSMA阳性前列腺癌治疗的安全性、耐受性及初步疗效的开放、多中心、Ib/II期临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601053608869671.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601053608869671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2488822045.USD","BK0239","LU0405327148.USD","LU0359201885.HKD","BK0012","LU1997245094.SGD","BK0028","600276","LU0359202008.SGD","LU1064131003.USD","LU1580142542.USD","BK0060","LU1969619763.USD","BK1191","LU2495084118.USD","BK0183","LU2097828474.EUR","LU2097828631.EUR","LU2289578879.USD","LU2097828714.EUR","LU1023057109.AUD","LU2543165471.USD","LU1997245177.USD","LU1064130708.USD","LU1820825898.SGD","LU2097828805.USD","LU1255011170.USD","LU2148510915.USD","LU1655091616.SGD","LU2328871848.SGD","LU2580892789.USD","BK0188","LU1146622755.USD","LU2097828557.USD","01276","BK0196","LU1328615791.USD","LU1997244956.HKD","LU0405327494.USD","LU1781817850.SGD","LU2580892862.HKD","LU0359201612.USD"],"gpt_icon":0},{"id":"2600152047","title":"恒瑞医药(01276)截至12月末累计回购A股股份889.87万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2600152047","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600152047?lang=zh_cn&edition=full","pubTime":"2026-01-04 18:48","pubTimestamp":1767523708,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药(01276)发布公告，2025年12月，公司通过上海证券交易所交易系统以集中竞价交易方式回购股份0股。截至2025年12月31日，公司本次股份回购方案累计通过上海证券交易所交易系统以集中竞价交易方式回购股份889.87万股，已回购股份占公司总股本的比例为0.13%，购买的最高价为人民币70.00元/股，最低价为人民币59.32元/股，已支付的总金额为人民币59,521.63万元(不含交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2097828474.EUR","BK0183","LU1997245177.USD","LU0359201885.HKD","BK0012","LU2097828714.EUR","LU0405327494.USD","LU2495084118.USD","LU2097828557.USD","BK0028","LU1064131003.USD","BK0239","LU2488822045.USD","LU0359202008.SGD","BK0196","BK0060","LU1997245094.SGD","LU1969619763.USD","399300","600276","LU1781817850.SGD","LU1580142542.USD","01276","BK1191","LU0359201612.USD","159982","LU2543165471.USD","LU2289578879.USD","LU1023057109.AUD","BK0188","LU1064130708.USD","LU1820825898.SGD","LU1255011170.USD","LU1997244956.HKD","LU1146622755.USD","LU2097828805.USD","LU0405327148.USD","LU2148510915.USD","LU1328615791.USD","LU2580892862.HKD","LU2328871848.SGD","LU2097828631.EUR","LU1655091616.SGD","LU2580892789.USD"],"gpt_icon":0},{"id":"2600054319","title":"智通AH统计|1月2日","url":"https://stock-news.laohu8.com/highlight/detail?id=2600054319","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600054319?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:15","pubTimestamp":1767341704,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止1月2日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为847.37%、398.38%、286.02%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-14.50%、-5.83%、-3.71%。其中浙江世宝、广和通、中船防务的偏离值位居前三，分别为86.11%、17.07%、11.89%；另外，东北电气、新华保险、广汽集团的偏离值位居后三，分别为-40.60%、-13.42%、-13.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0593848301.USD","BK1562","LU1008478684.HKD","SG9999001226.SGD","LU0345780281.USD","LU0828237510.HKD","LU2778985437.USD","002703","BK1509","LU0049853897.USD","LU0163747925.USD","HK0000306701.USD","LU0359202008.SGD","IE00BVYPNQ40.USD","LU0823426480.USD","BK1583","LU1808992512.USD","159982","LU0348788117.USD","CIHKY","LU0359201612.USD","LU1152091754.HKD","BK1539","LU0540923850.HKD","LU0449515922.USD","LU0456827905.SGD","BK1506","BK1584","BK1521","LU0463099449.HKD","SG9999014674.SGD","IE0031814852.USD","03143","LU1152091168.USD","LU2226246903.HKD","IE00B031J352.USD","LU1115378108.SGD","LU0214875030.USD","IE00BGHQDM52.EUR","LU0266512127.USD","BK1514","IE00BYV24P56.USD","LU1675838814.USD","BK1163","LU2039709279.SGD","LU0307460666.USD","BK1119","03968","HK0000306685.HKD","BK1141","BK1515","BK1551","LU0708995583.HKD","LU1048596156.SGD","00042","IE00BZ08YS42.EUR","IE0008368742.USD","IE00B5MMRT66.SGD","SG9999002463.SGD","LU0572944931.SGD","LU0181495838.USD","LU0106252389.USD","LU0039217434.USD","LU0823426308.USD","LU0229945570.USD","LU0886674414.USD","LU2543165471.USD","LU0862451753.SGD","LU0140636845.USD","LU0244354667.USD","LU0823040885.USD","LU0384037296.USD","LU1282649810.SGD","BK1129","LU1303224171.USD","LU0737861699.HKD","LU0890818403.SGD","LU1719994722.HKD","LU2097828805.USD","BK1202","BK1592","LU0348805143.USD","BK1147","BK1214","BK1550","LU1328277881.USD","LU1961090484.USD","LU2097828631.EUR","BK1558","LU0052750758.USD","LU0828237940.HKD","BK1205","LU1226287529.USD","IE00B031HY20.USD","IE00B543WZ88.USD","LU0054450605.USD","LU0516422440.USD","BK1191","LU2097828557.USD","LU0417516902.SGD","HK0000500386.USD","LU0228659784.USD","LU1282649067.USD","BK1560","LU0531971595.HKD","BK1116","BK1173","HK0000252160.HKD","LU1769817096.USD","LU0516422952.EUR","600276","BK1523","LU0791591158.USD","BK1607","BK1594","LU2476274308.USD","BK1105","BK1505","LU1211504680.USD","399300","LU1720050803.USD","LU1770034418.SGD","LU0326950275.SGD","BK1124","LU0501845795.SGD","LU0871576103.HKD","300750","LU1794554557.SGD","LU0328353924.USD","BK1610","LU2097828474.EUR","LU0868486357.SGD","BK1526","IE0034224299.USD","IE00B29SXG58.USD","BK1184","LU0329678170.USD","LU0502904849.HKD","LU0327786744.USD","IE00BZ08YT58.USD","LU0072913022.USD","LU0516423174.USD","LU0640798160.USD","LU1366334651.USD","LU1366334578.USD","LU1831875114.USD","LU2097828714.EUR","LU0173614495.USD","BK1149","LU0264606111.USD","BK1507","LU0106959298.USD","LU0348735423.USD","LU0117841782.USD","LU0348827113.USD","LU1224709979.USD","LU0543330566.HKD","BK1614","LU0821914370.USD","LU1769817179.HKD","LU0516422366.SGD","LU0880133367.SGD","LU0314109678.HKD","HK0000320264.USD","LU1242518857.USD","LU0455707207.USD","LU0231483743.USD","LU0211977185.USD","LU2242644610.SGD","LU0149721374.USD","LU0417516738.SGD","LU0737861772.HKD","LU0164865239.USD","LU1242518931.SGD","BK1183","LU0048580855.USD","LU1807302812.USD","LU2399975544.HKD","IE00BMCWC346.EUR","BK1144","LU0320764599.SGD","LU2476274720.SGD","LU0348816934.USD","BK1190","HK0000252152.HKD","LU1282648689.USD","LU0315179316.USD","BK1171","BK1546","LU0588546209.SGD","LU2125910500.SGD","LU0345780521.USD","LU0254981946.USD","03678","BK1154","01057","LU0228367735.SGD","LU0572940350.SGD","LU0431992006.USD","SG9999004220.SGD","BK1231","LU1880383366.USD","LU0266512473.USD","LU0918141887.USD","LU0531970944.HKD","IE00B0169L03.USD","LU0096374516.USD","LU0918141705.HKD","LU0572939691.SGD","LU0370786039.SGD","IE00BVYPNP33.GBP","LU0648948544.HKD","LU0634319403.HKD","LU1105468828.SGD","LU0359201885.HKD","SG9999003461.SGD","IE00B3M56506.USD","BK1544","01276","IE0008369823.USD","LU0067412154.USD","IE00BZ08YR35.GBP","LU1960683339.HKD","BK1576","BK1535","LU2045819591.USD","001236","LU0348814723.USD","LU0449509016.USD","LU1504937902.USD","LU1880383440.USD","LU1481107354.HKD","SG9999006597.SGD","LU0589944569.HKD","LU0456854461.SGD","LU0791590937.USD","BK1179","BK1522","LU0469268626.HKD","LU1023057109.AUD","LU1251922891.USD","LU1993786604.SGD","LU1188198961.HKD","600036","LU1813983027.USD","LU0164880469.USD","LU0348825331.USD","LU1282649141.HKD","BK1198","IE00BF5LJ272.USD","LU0061477393.USD","LU0329678337.USD","LU0561508036.HKD","LU1046422090.SGD","BK1564","LU0287142896.SGD","LU0456846285.SGD","BK1223","LU0051755006.USD","LU0979878070.USD","LU0488056044.USD","LU1688375341.USD","BK1237","LU0516423091.SGD","HK0000320223.HKD","BK1554","SG9999002828.SGD","LU0797268264.HKD"],"gpt_icon":1},{"id":"2600056352","title":"港股异动 | 恒瑞医药(01276)午后涨超5% CLDN18.2 ADC胃癌适应症纳入突破性治疗品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2600056352","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600056352?lang=zh_cn&edition=full","pubTime":"2026-01-02 13:43","pubTimestamp":1767332632,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，恒瑞医药午后涨超5%，截至发稿，涨5.19%，报74.95港元，成交额5568.71万港元。消息面上，恒瑞医药宣布，其自主研发的靶向Claudin18.2的抗体药物偶联物——注射用SHR-A1904，已被国家药品监督管理局药品审评中心正式纳入突破性治疗品种名单。该药物拟用于治疗既往接受过至少一线系统治疗的CLDN18.2阳性的局部晚期或转移性胃或胃食管交界处腺癌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","LU1064130708.USD","BK0183","LU2148510915.USD","BK0028","LU1655091616.SGD","BK1191","LU2580892862.HKD","600276","01276","LU0359202008.SGD","LU2488822045.USD","LU1023057109.AUD","LU0359201885.HKD","LU2289578879.USD","LU1781817850.SGD","LU0405327494.USD","LU2495084118.USD","ADC","BK0188","BK0012","LU1820825898.SGD","LU1580142542.USD","BK4231","LU2097828805.USD","LU2097828631.EUR","LU2097828474.EUR","LU2328871848.SGD","LU2543165471.USD","LU2097828557.USD","LU1146622755.USD","LU2580892789.USD","LU1328615791.USD","LU1997245177.USD","LU1255011170.USD","LU1997245094.SGD","BK0239","BK4080","BK0196","LU2097828714.EUR","LU1969619763.USD","LU1997244956.HKD","LU1064131003.USD","LU0359201612.USD","LU0405327148.USD"],"gpt_icon":0},{"id":"2595792596","title":"恒瑞医药六款创新药获临床试验批件，肿瘤管线再扩容","url":"https://stock-news.laohu8.com/highlight/detail?id=2595792596","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595792596?lang=zh_cn&edition=full","pubTime":"2025-12-30 20:26","pubTimestamp":1767097566,"startTime":"0","endTime":"0","summary":"中访网数据 江苏恒瑞医药股份有限公司及其子公司近日宣布，其自主研发及引进的六款抗肿瘤新药已获得国家药品监督管理局颁发的药物临床试验批准通知书，即将进入临床研究阶段。此次获批的药品包括SHR-4375注射液、阿得贝利单抗注射液、SHR-8068注射液、贝伐珠单抗注射液、HRS-4642注射液及注射用SHR-9839，将联合开展一项针对晚期实体肿瘤患者的Ib/II期临床研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251230/31904557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2148510915.USD","LU1064131003.USD","LU1969619763.USD","LU2580892862.HKD","LU2495084118.USD","BK0196","LU1023057109.AUD","LU1064130708.USD","BK1161","LU2097828557.USD","BK0028","LU1255011170.USD","LU2543165471.USD","159992","LU1146622755.USD","LU1580142542.USD","BK0183","LU1997244956.HKD","600276","LU1328615791.USD","LU2097828714.EUR","LU1997245094.SGD","LU1781817850.SGD","LU1997245177.USD","LU2488822045.USD","LU0359201885.HKD","LU2097828631.EUR","BK0012","LU0405327148.USD","BK0060","01276","BK0239","BK0188","LU2328871848.SGD","LU2580892789.USD","LU0359201612.USD","BK1191","LU2097828474.EUR","LU0359202008.SGD","LU1820825898.SGD","06978","LU1655091616.SGD","LU0405327494.USD","LU2289578879.USD","BK1574","LU2097828805.USD"],"gpt_icon":0},{"id":"2595782399","title":"恒瑞医药SHR-4375注射液等6款药品临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2595782399","media":"北京商报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595782399?lang=zh_cn&edition=full","pubTime":"2025-12-29 19:16","pubTimestamp":1767006961,"startTime":"0","endTime":"0","summary":"北京商报讯12月29日，恒瑞医药发布公告称，公司及子公司上海恒瑞医药有限公司、上海盛迪医药有限公司、苏州盛迪亚生物医药有限公司收到国家药品监督管理局核准签发关于SHR-4375注射液、阿得贝利单抗注射液、SHR-8068注射液、贝伐珠单抗注射液、HRS-4642注射液、注射用SHR-9839（sc）的《药物临床试验批准通知书》，将于近期开展临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512293604578310.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512293604578310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2097828714.EUR","LU0405327148.USD","LU2488822045.USD","LU1997245177.USD","600276","LU2148510915.USD","BK0188","LU1328615791.USD","BK0012","LU1255011170.USD","BK0239","BK0028","LU1997245094.SGD","LU2097828631.EUR","LU2580892862.HKD","BK0183","LU2097828474.EUR","LU0359201612.USD","LU0359201885.HKD","LU0359202008.SGD","LU1023057109.AUD","LU2328871848.SGD","01276","LU0405327494.USD","LU1997244956.HKD","BK0196","LU1820825898.SGD","LU2097828557.USD","LU1146622755.USD","LU2289578879.USD","LU2543165471.USD","LU1969619763.USD","LU1580142542.USD","BK1191","LU2580892789.USD","LU1781817850.SGD","BK0060","LU1064131003.USD","LU1064130708.USD","LU1655091616.SGD","LU2097828805.USD","LU2495084118.USD"],"gpt_icon":0},{"id":"2595781654","title":"智通港股空仓持单统计|12月29日","url":"https://stock-news.laohu8.com/highlight/detail?id=2595781654","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595781654?lang=zh_cn&edition=full","pubTime":"2025-12-29 18:30","pubTimestamp":1767004204,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止12月19日，未平仓空单比位列前三位为万科企业、中远海控、恒瑞医药，空仓比分别为18.48%、16.79%、15.54%。未平仓空单比（绝对值）较上一次增加最多为宁德时代、蓝思科技、优必选，分别增加2.35%、2.34%、1.29%。智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；以上涉及的空仓比增加值或减少值为绝对值数。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008368742.USD","LU1634259391.SGD","BK1610","BK1546","PAImain","LU0865486749.SGD","LU0878004406.USD","LU0588545904.SGD","LU0823426480.USD","LU0348827113.USD","LU1115378108.SGD","LU1497734951.SGD","SG9999001093.SGD","BK1561","BK1207","SG9999002828.SGD","HPAD.SI","LU1794554557.SGD","LU0359201612.USD","LU1044876610.USD","LU0314109678.HKD","BK1131","LU1303224171.USD","LU1807302812.USD","SG9999002463.SGD","BK1592","LU0762542818.HKD","LU1023057109.AUD","LU0572944931.SGD","LU1981816686.USD","HK0000320223.HKD","LU1808992512.USD","LU0762540952.USD","SG9999004311.SGD","LU0149721374.USD","BK1564","BK1149","LU0165289439.USD","BK1169","LU0634319403.HKD","LU1522347837.USD","LU0531971595.HKD","LU1504937902.USD","BK1506","HK0000252160.HKD","LU0918141887.USD","LU0211977185.USD","LU0328353924.USD","LU0651947912.USD","LU1282651048.USD","LU0791591158.USD","LU0878005551.USD","600276","BK1135","LU0072462343.USD","LU1497733631.SGD","LU0228659784.USD","LU0329678170.USD","LU0348788117.USD","LU0072913022.USD","LU2097828631.EUR","BK1612","LU1282648689.USD","LU0588546209.SGD","BK1521","LU0049112450.USD","LU0417516902.SGD","000002","LU0630378429.USD","601919","LU0315178854.USD","LU0651946864.USD","LU0348825331.USD","HK0000252152.HKD","HK0000306685.HKD","BK1554","LU2226246903.HKD","SG9999014674.SGD","BK1504","BK1594","BK1556","300750","LU0196878994.USD","LU1831875114.USD","LU1719994722.HKD","LU0348783233.USD","LU0640798160.USD","LU1481107354.HKD","BK1583","LU0737861772.HKD","LU0417516738.SGD","LU1224444064.USD","LU0266512127.USD","LU0828237940.HKD","LU0463099449.HKD","LU0588545490.SGD","IE00B29SXG58.USD","IE0034224299.USD","01919","LU0501845795.SGD","BK1607","BK1228","LU1961090484.USD","LU0348767384.USD","LU0067412154.USD","IE00BVYPNQ40.USD","BK1544","80020","BK1161","LU0048580855.USD","LU2293587155.HKD","BK1205","LU0164865239.USD","BK1198","BK1104","HK0000306701.USD","LU0819121731.USD","LU1044875133.USD","LU0762541174.USD","IE00BZ08YT58.USD","BK1589","LU0630378692.HKD","HK0000320264.USD","LU0797268264.HKD","LU1770034418.SGD","LU1880383440.USD","HK0000500386.USD","BK1188","LU1051768304.USD","LU2543165471.USD","LU0049853897.USD","LU0708995583.HKD","BK1588","LU0320764599.SGD","BK1550","LU0051755006.USD","LU1051769294.HKD","SG9999006597.SGD","BK1595","LU0039217434.USD","BK1555","LU0061477393.USD","LU1046422090.SGD","LU2476274720.SGD","03750","LU0043850808.USD","LU2039709279.SGD","BK1516","LU1008478684.HKD","LU2097828714.EUR","LU1366334651.USD","LU0348735423.USD","SG9999004220.SGD","601318","LU0370786039.SGD","BK1563","LU1048588211.SGD","06613","LU1044874839.SGD","LU0327786744.USD","LU0605514214.HKD","SG9999001051.SGD","LU0181495838.USD","LU1813983027.USD","BK1191","LU1769817179.HKD","LU0890818403.SGD","LU0561508036.HKD","LU1188198961.HKD","LU1235295612.USD","LU1720050803.USD","LU0880133367.SGD","BK1103","LU0611395673.USD","IE00BF5LJ272.USD","LU0106252389.USD","LU1282649810.SGD","BK1503","LU1282649067.USD","LU1282651121.HKD","LU0828237510.HKD","LU2242644610.SGD","LU0235996351.USD","IE00BVYPNP33.GBP","LU1242518857.USD","LU1251922891.USD","LU2476274308.USD","LU0856984785.SGD","LU0348805143.USD","LU2778985437.USD","IE00BZ08YS42.EUR","LU1211504680.USD","01276","BK1141","LU0054450605.USD","LU0254981946.USD","LU0594300419.USD","LU0348814723.USD","LU0488056044.USD","SG9999003461.SGD","LU0456854461.SGD","BK1196","LU1642822792.SGD","LU1048596156.SGD","BK1523","LU0345780281.USD","BK1183","01318","BK1576","BK1240","LU1105468828.SGD","BK1505","LU0791590937.USD","LU1634259557.SGD","IE00BMCWC346.EUR","03145","IE00BYV24P56.USD","02202","LU0862451753.SGD","LU1675838814.USD","BK1526","LU2348774022.SGD","LU1960683339.HKD","LU0540923850.HKD","LU0315179316.USD","BK1618","BK1615","LU1515016050.SGD","BK1613","LU0197773160.USD","LU0831093199.SGD","BK1501","LU1152091754.HKD","BK1604","300433","BK1522","LU0348783662.USD","LU2097828805.USD","SG9999002562.SGD","LU0384037296.USD","BK1127","BK1575","IE0003895053.USD","LU0140636845.USD","LU0469268626.HKD","LU2399975544.HKD","LU1769817096.USD","BK1095","LU1497733557.USD","LU0326950275.SGD","LU0449515922.USD","LU0650527681.SGD","BK1184","LU0348784397.USD","LU2488822045.USD","LU1993786604.SGD","LU0918141705.HKD","LU1328277881.USD","82318","LU0163747925.USD","LU0266512473.USD","LU0979878070.USD","BK1619","LU0244354667.USD","BK1109","LU0106959298.USD","BK1507","LU1366334578.USD","LU1152091168.USD","LU0886674414.USD","LU2153592121.USD","LU1282649141.HKD","LU0359201885.HKD","601869","BK1515","LU0164880469.USD","LU0588545730.USD","BK1168","LU0882747503.HKD","PNGAY","LU2125910500.SGD","LU0737861699.HKD","LU0197773673.USD","LU0307460666.USD","LU0084288322.USD","IE00BZ08YR35.GBP","LU1242518931.SGD","LU0173614495.USD","LU0456827905.SGD","BK1529","LU0871576103.HKD","BK1587","LU2097828474.EUR","LU0594300179.USD","BK1116","BK1608","LU0345780521.USD","LU0164872284.USD","LU2045819591.USD","IE00BGHQDM52.EUR","LU0096374516.USD","LU0821914370.USD","LU0348766576.USD","LU0819123356.HKD","LU1226287529.USD","LU2097828557.USD","BK1147","LU0348816934.USD","00357","SG9999001069.SGD","BK1535","LU1224709979.USD","LU0823426308.USD","LU0293314216.USD","LU0359202008.SGD","LU0417516571.SGD","LU0648948544.HKD","BK1170","LU1880383366.USD","LU0228367735.SGD","LU0052750758.USD","SG9999001440.SGD","LU0329678337.USD","LU0287142896.SGD"],"gpt_icon":1},{"id":"2594822143","title":"恒瑞医药(600276.SH)与翰森制药签署SHR6508项目独家许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2594822143","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594822143?lang=zh_cn&edition=full","pubTime":"2025-12-28 16:43","pubTimestamp":1766911410,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药 公告，公司与翰森制药集团有限公司签署《独家许可协议》，将公司SHR6508项目有偿许可给翰森制药;公司子公司成都盛迪医药有限公司与翰森制药子公司江苏豪森药业集团有限公司签署《商业化服务框架协议》，委托豪森药业为公司帕立骨化醇软胶囊产品提供非独家商业化服务。公司帕立骨化醇软胶囊于2025年11月获得国家药监局批准上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386213.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064131003.USD","LU0359201612.USD","LU1997244956.HKD","LU2495084118.USD","BK1589","LU1328615791.USD","LU1146622755.USD","BK1583","LU1255011170.USD","LU2148510915.USD","BK0239","LU2097828474.EUR","LU1655091616.SGD","03692","LU0405327494.USD","LU1997245094.SGD","LU1580142542.USD","BK0196","LU2097828631.EUR","LU1781817850.SGD","LU1064130708.USD","LU2097828714.EUR","BK0188","LU1820825898.SGD","LU2097828557.USD","LU2289578879.USD","LU2097828805.USD","LU0359202008.SGD","BK1191","600276","LU2580892862.HKD","LU2488822045.USD","BK0012","LU0359201885.HKD","LU2580892789.USD","BK0060","BK0183","LU0405327148.USD","LU2543165471.USD","LU1023057109.AUD","LU2328871848.SGD","BK0028","LU1997245177.USD","01276","LU1969619763.USD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768292346419,"stockEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.009},{"period":"3month","weight":-0.0065},{"period":"6month","weight":0.1159},{"period":"1year","weight":0.5018},{"period":"ytd","weight":0.0718}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":0.0709},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1888},{"period":"1year","weight":0.3146},{"period":"ytd","weight":0.0495}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏恒瑞医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"397246人(较上一季度增加8.94%)","perCapita":"16058股","listingDate":"2000-10-18","address":"江苏省连云港市连云区经济技术开发区黄河路38号","registeredCapital":"663719万元","survey":"　　江苏恒瑞医药股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是硫培非格司亭注射液、马来酸吡咯替尼片、注射用卡瑞利珠单抗、瑞维鲁胺片、海曲泊帕乙醇胺片、碘佛醇注射液。","listedPrice":11.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"恒瑞医药(600276)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供恒瑞医药(600276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"恒瑞医药,600276,恒瑞医药股票,恒瑞医药股票老虎,恒瑞医药股票老虎国际,恒瑞医药行情,恒瑞医药股票行情,恒瑞医药股价,恒瑞医药股市,恒瑞医药股票价格,恒瑞医药股票交易,恒瑞医药股票购买,恒瑞医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"恒瑞医药(600276)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供恒瑞医药(600276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}